Magnesium sulfate heptahydrate 99.0-100.5% (by anhydrous basis), crystals USP, Multi-Compendial, J.T.Baker®
Supplier: AVANTOR PERFORMANCE MATERIAL LLC
Synonyms:
sulfuric acid magnesium salt heptahydrate
, Bitter salt
, sulphuric acid magnesium salt heptahydrate
, Epsom salt
Management of Change (MOC) category = R
BAKR2504-07
BAKR2504-07
BAKR2504-01
BAKR2504-QM
BAKR2504-08
BAKR2504-05
BAKR2504-05
BAKR2504-08
BAKR2504-01
BAKR2504-QM
JT2504-1CS
1031.43
USD
JT2504-1
CAJT2504-8
CAJT2504-7
JT2504-QM
CAJT2504-5
CAJT2504-QM
JT2504-8
JT2504-7
CAJT2504-1
JT2504-5
Magnesium sulfate heptahydrate 99.0-100.5% (by anhydrous basis), crystals USP, Multi-Compendial, J.T.Baker®
Magnesium sulphate heptahydrate
- GMP manufactured product
Formula:
MgSO₄·7H₂O MW: 246.48 g/mol Melting Pt: 1124 °C Density: 1.67 g/cm³ Storage Temperature: Ambient |
MDL Number:
MFCD00149785 CAS Number: 10034-99-8 EINECS: 231-298-2 Merck Index: 13,05715 |
Specification Test Results
Meets B.P. Chemical Specifications | |
Meets E.P. Chemical Specifications | |
GMP Manufactured Product | |
Meets U.S.P Requirements | |
Preserve in well-closed containers. | |
CAUTION: For Manufacturing, processing or repackaging | |
Bulk Pharmaceutical Chemical | |
USP - Identification | Passes Test |
USP - pH (1 in 20) | 5.0 - 9.2 |
USP - Loss on Ignition | 40.0 - 52.0 % |
USP - Chloride (Cl) | ≤ 0.014 % |
USP - Iron (Fe) | ≤ 0.5 ppm |
USP - Selenium (Se) | ≤ 0.003 % |
USP - Assay (MgSO₄) (anhydrous basis) | 99.0 - 100.5 % |
USP - Endotoxin Concentration (EU/g) | ≤ 2.5 |
EP/BP - Identification A | Passes Test |
EP/BP - Identification B | Passes Test |
EP/BP - Appearance of Solution | Passes Test |
EP/BP - Acidity or Alkalinity | Passes Test |
EP/BP - Chloride (Cl) | ≤ 300 ppm |
EP/BP - Iron (Fe) | ≤ 20 ppm |
EP/BP - Loss on Drying | 48.0 - 52.0 % |
EP/BP - Assay (MgSO₄) (anhydrous basis) | 99.0 - 100.5 % |
Solution Test | Passes Test |
No Class 1,2,3 or other solvents are used or produced in the | |
manufacturing or purification of the product. | |
Elemental Impurities (USP 232, EP 5.20) - Information on | |
elemental impurities for this product is available on the | |
associated Product Regulatory Data Sheet and elemental impurity | |
profile report. | |
This product is intended for use in preparing parenteral and | |
nonparenteral dosage forms. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...